Zusammenfassung
Die intraerythrozytäre Ferritinkonzentration ist zusätzlich zur Serum- bzw. Plasmaferritin-konzentration [9] für die Beurteilung des Eisenhaushalts geeignet [3]. Bei latentem Eisenmangel ist die Ferritinkonzentration in den Erythrozyten im Gegensatz zu der im Plasma überwiegend normal [3], fällt aber hochsignifikant bei manifester Eisenmangelanämie ab [3, 13].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Beamish MR, Walker R, Miller F, Worwood M, Jacobs A, Williams R, Corrigall A (1974) Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis. Br J Haematol 27: 219–228
Birgegård G, Högman C, Killander A, Levander H, Simonsson B, Wide L (1977) Serum ferritin and erythrocyte 2,3 DPG during quantitated phlebotomy and iron treatment. Scand J Haematol 19:327–333
Bodemann HH, Rieger A, Löhr GW (1982) Intraerythrozytäre Ferritinkonzentration und Eisenbestand. Verh Dtsch Ges Inn Med 88:993–995
Bomford AB, Munro HN (1980) Biosynthesis of ferritin and isoferritins. In: Jacobs A, Worwood M (eds) Iron in biochemistry and medicine, II. Academic Press, London New York, pp 173–202
Drews J, Düllmann J, Hausmann K, Kuse R (1980) Die Serumferritinbestimmung in Diagnostik und Therapie der Eisenüberladung. In: Kaltwasser JP, Werner E (Hrsg) Serumferritin. Springer, Berlin Heidelberg New York, S 194–210
Finch CA, Huebers H (1982) Perspectives in iron metabolism. N Engl J Med 306: 1520–1528
Jacobs A (1980) The pathology of iron overload. In: Jacobs A, Worwood M (eds) Iron in biochemistry and medicine, II. Academic Press, London New York, pp 427–459
Kaltwasser JP, Werner E, Becker HJ (1977) Serumferritin als Kontrollparameter bei oraler Eisentherapie. Dtsch Med Wochenschr 102: 1150–1155
Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290: 1213–1216
Schaefer FV, Theil EC (1981) The effect of iron on the synthesis and amount of ferritin in red blood cells during ontogeny. J Biol Chem 256: 1711–1715
Wheby MS (1980) Effect of iron therapy on serum ferritin levels in iron-deficiency anemia. Blood 56:138–140
Worwood M (1980) Serum ferritin. In: Jacobs A, Worwood M (eds) Iron in biochemistry and medicine, II. Academic Press, London New York, pp 203–244
Yamada H (1978) Characterization of serum and red cell ferritin in hematological disorders. Acta Haematol Jpn 41:1334–1338
Zähringer J (1980) Struktur und Funktion von Ferritin. In: Kaltwasser JP, Werner E (Hrsg) Serumferritin. Springer, Berlin Heidelberg New York, S 1–22
Literatur
Dunn CDR, Jarois JH, Greenman JM (1975) A quantitative bioassay for erythropoietin using mouse foetal liver cells. Exp Hematol 3: 365
Heilmann E, Holzknecht A, Fahrenkrug H (1981) Hinweise auf einen hämatopoetisch wirksamen Faktor im Serum von Patienten mit Polycythaemia vera. Verh Dtsch Ges Inn Med 87: 772
Heilmann E, Ridderskamp P, Maurer HR (1982) A micromethod to culture hematopoietic colonies in glass capillaries. Exp Hematol 10: 146
Iscove NN, Scun JS, Till JS, McCulloh EA (1971) Colony formation by normal and leukemic human marrow cells in culture, effect of conditioned medium from human leukocytes. Blood 37: 1
Kansal V, Sood SK, Batra AK, Adhar G, Malviya AK, Kucheria K, Balakrishnan K (1979) Fetal liver transplantation in aplastic anemia. Acta Haematol (Basel) 62:128
Literatur
Aster RH (1966) Pooling of platelets in the spleen: Role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest 45:645–657
Korinth E (1962) Untersuchungen über die quantitativen morphologischen und funktionellen Veränderungen der Thrombozyten bei chronischen Lebererkrankungen. Acta Hepatogastroenterol (Stuttg) 9:65–73
Leone G et al. (1981) Mega-thrombocytes, platelet regeneration time and platelet associated IgG in idiopathic thrombocytopenic purpura and in thrombocytopenia associated with chronic liver disease. Acta Haematol (Basel) 65: 40–47
Pennington DG, Streatfield K (1975) Megacaryocytes and the heterogeneity of circulating platelets. Br J Haematol 34: 639–653
Penny R, Rozenberg MC, Firkin BG (1966) The splenic platelet pool. Blood 27:1–16
Scharf RE, Heisig S, Winkelmann M, Schneider W (1983) Erhöhte thrombozytäre Sialinsäurekonzentration bei Leberzirrhose. Verh Dtsch Ges Inn Med 89:990
Siemensma NP, Bathal PS, Pennington PG (1975) The effect of massive liver resection on platelet kinetics in the rat. J Lab Clin Med 86: 817–833
Stein SF, Harker LA (1982) Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 99:217–230
Literatur
Brozović M (1981) Aquired disorers of blood coagulation. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis. Churchill Livingstone, Edinburgh, pp 411–438
Deutsch E (1982) Hämostasestörungen bei Lebererkrankungen. Bildungsstörungen. Verh Dsch Ges Inn Med 88:1330–1335
Mannucci PM, Mari D (1981) Hemostasis and liver disease. Haematologica (Pavia) 66: 233–248
Martinez J, Kwasniak D (1977) Role of sialic acid in the dysfibrinonenaemia associated with liver disease. Thromb Haemostas 38:169 (Abstract)
Rubin MH, Weston MJ, Langley PG, White Y, Williams R (1979) Platelet function in chronic liver disease. Relationship to disease severity. Dig Dis Sci 24:197–202
Schneider W, Scharf RE, Schramm W (1982) Hämostasestörungen bei Lebererkrankungen. Thrombozyten und Lebererkrankungen. Verh Dtsch Ges Inn Med 88:1336–1339
Soria J, Soria S, Samana M, Coupier J, Girard ML, Bousser J, Bilskipasquier G (1970) Dysfibrinogénémie acquise dans les atteintes hépatiques sévères. Coagulation 3:37–44
Stein SF, Harker LA (1982) Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 99: 217–230
Warren L (1959) The thiobarbituric acid assay of sialic acids. J Biol Chem 234:1971–1975
Winkelmann M, Schneider W, Schmitz G, Aul C, Scharf RE, Pfitzer P (1983) Reifestadienverteilung und Polyploidiemuster der Megakaryozyten bei Patienten mit Leberzirrhose. Verh Dtsch Ges Inn Med 89 (im Druck)
Literatur
Braine HG, Sensenbrenner LL, Wright SK, Tuschka PJ, Sarai R, Santos GW (1982) Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 60:420–425
Camitta BM, Thomas ED, Nathan DG, Santos GW, Gordon-Smith EC (1975) Severe aplastic anemia: An indication for marrow transplantation. Blood 46:1001–1007
Cline MJ, Gale RP, Stiehm ER, Opelz G, Lowell SY, Feig SA, Fahey JL (1975) Bone marrow transplantation in man. Ann Intern Med 83: 691–701
Hinterberger W, Schmidmeier W, Höcker P, Neumann E, Lechner K (1982) Prognostic significance of the number of myeloid committed stem cells (CFUc-GM) in the bone marrow and blood of patients with aplastic anemia. Exp Haematol (in press)
Kersey JH (1983) Prevention of graft versus host disease. J Cell Biochem (Suppl) 7A: 116 (Abstract)
Lynch RE, Williams DM, Reading JC, Cartwright GD (1975) The prognosis in aplastic anemia. Blood 45:517–525
Pike BI, Robinson WA (1970) Human bone marrow colony growth in agar-gel. J Cell Physiol 76: 77–84
Storb R, Doney K, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg J, Goodall BW, Hackman R, Hansen JA, Sanders JA, Sullivan KM, Weiden PL, Witherspoon RP (1982) Transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59: 236–243
Storb R, Prentice RL, Thomas ED (1977) Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296: 61–66
Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodall BW, Sale GE, Sanders JA, Singer J, Stewart P, Weiden PL (1980) Marrow transplantation in thirty untransfused patients with severe aplastic anemia. Ann Intern Med 92:30–38
Literatur
Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantations for treatment of severe aplastic anaemia. Blood 53: 504–514
Ramsay NKC, Kim T, Nesbit ME, Krivit W, Coccia PF, Levitt SH, Woods WG, Kersey JH (1980) Total lymphoid irradition and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 55: 344–346
Schmeiser T, Arnold R, Kurrle E, Kubanek B, Pflieger H, Heimpel H, Krieger D (1983) Infection prophylaxis in bone marrow transplantation with two different methods of gnotobiotic care. Exp Hematol (in press)
Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Goodell BW, Johnson FL, Neiman PE, Sanders JE, Singer J (1978) One-hundred-ten patients with aplastic anemia (AA) treated by bone marrow transplantation in Seattle. Transplant Proc 10:135–140
Storb R, Thomas ED, Buckner CD, Clift RA, Deeg J, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL (1980) Marrow transplantation in thirty “untransfused” patients with severe aplastic anemia. Ann Intern Med 92:30–36
Literatur
Alexanian R, Balcerzak S, Bonnet JD, Gehan EA, Haut A, Hewlett JS, Monto RW (1975) Prognostic factors in multiple myeloma. Cancer 36: 1192–1201
Bayrd ED (1948) The bone marrow on sternal aspiration in multiple myeloma. Blood 3: 987–1018
Bergsagel D (1976) Annotation: The treatment of plasma cell myeloma. Br J Haematol 33: 443–449
Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc [B] 34:187–220
Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36: 842–854
Ludwig H (1982) Multiples Myelom. Springer, Berlin Heidelberg New York
Matzner Y, Benbassat J, Polliack A (1978) Prognostic factors in multiple myeloma. Acta Haematol (Basel) 60:257–268
Merlini G, Waldenström JG, Jayakar SD (1980) A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood 55:1011–1018
Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas. Cancer 49: 2112–2135
Vercelli D, Di Guglielmo R, Guidi G, Scolari L, Buricchi L, Cozzolino F (1980) Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies. Nouv Rev Fr Hematol Blood Cells 22: 139–145
Wutke K, Rüdiger KD, Kelényi G (1979) Prognoserelevante klinische und morphologische Klassifikation des multiplen Myeloms. Arch Geschwulstforsch 49: 671–684
Literatur
Fourth International Workshop on Chromosomes in Leukemia (1982) Cancer Genet Cytogenet (in press)
Third International Workshop in Chromosomes in Leukemia, 1980 (1981): Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases. Cancer Genet Cytogenet 4:101–110
Third International Workshop on Chromosomes in Leukemia, 1980 (1981): Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 4:111–137
Esseltine DW, Vekemans M, Seemayer T, Reece E, Gordon J, Whitehead VM (1982) Significance of a (4; 11) translocation in acute lymphoblastic leukemia. Cancer 50: 503–506
Morse HG, Heideman R, Hays T, Robinson A (1982) 4; 11 translocation in acute lymphoblastic leukemia: a specific syndrome. Cancer Genet Cytogenet 7:165–172
Oshimura M, Freeman A, Sandberg AA (1977) Chromosomes and causation of human cancer and leukemia. XXVI. Banding studies in acute lymphoblastic leukemia (ALL). Cancer 40:1161–1172
Parkin JL, Arthur DC, Abramson CS, McKenna RW, Kersey JH, Heideman RL, Brunning RD (1982) Acute leukemia associated with the t (4; 11) chromosome rearrangement: ultrastructural and immunologic charakte-ristics. Blood 60:1321–1331
Prigogina EL, Fleischman EW, Puchkova GP, Kulagina OE, Majakova SA, Balakirev SA, Frenkel MA, Khvatova NV, Peterson IS (1979) Chromosomes in acute leukemia. Hum Genet 53: 5–16
Van den Berghe H, David G, Broeckaert-van Orshoven A, Louwagie A, Verwilghen R, Casteels-Van Deele M, Eggermont E, Eeckels R (1979) A new chromosome anomaly in acute lymphoblastic leukemia (ALL). Hum Genet 46:173–180
Literatur
Benöhr H, Reu G, Wilms K, Waller HD (1980) Langjährige Überlebenszeit bei Erwachsenen mit akuter Leukämie. Blut 40: 399–406
Gerecke D, Hirschmann WD, Voigtmann R, Gross R (1979) Remission induction and remission maintenance in adult acute non-lymphocytic leukemia employing a modified cytostatic (COAP) regimen. Blut 39: 39–45
Gerecke, D, Kreß M, Hirschmann WD (1983) Long term follow-up of remission patients in adult acute leukemia. Klin Wochenschr (im Druck)
Literatur
Crowther D (1981) New approaches to the management of patients with Non-Hodgkin’s lymphoma of high grade pathology. Br J Cancer 43:417–435
Jones SE, Miller T (1982) Chemotherapy of malignant lymphomas of unforable histology. In: Rosenberg SA, Kaplan HJ (eds) Malignant lymphomas. Academic Press
McKelvey E, Gottlieb J, Wilson E et al. (1976) Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484–1493
De Vita VT, Mubbard SM (1982) The curative potential of chemotherapy in the treatment of Hodgkin’s disease and Non-Hodgkin’s lymphomas. In: Rosenberg SA, Kaplan HJ (eds) Malignant lymphomas. Academic Press
Literatur
Wördehoff D (1981) Diagnostischer Wert laborchemischer Ascitesuntersuchungen. Leber Magen Darm 1:25–30
Storey D et al. (1976) Pleural effusion. JAMA 236:2183–2185
Ali IU, Hunter T (1981) Structural comparison of fibronectins from normal and transformed cells. J Biol Chem 25:7671–7677
Literatur
McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65:1201–1207
Stedman KE, Moore GE, Morgan RT (1980) Estrogen receptor proteins in diverse human tumors. Arch Surg 115: 244–248
Bojar H, Stuhldreier B, Becher R, Koldorsky V, Goerz G, Merk H, Staib W (1982) Gradient centrifugation analysis of steroid-hormone binding in human malignant melanoma. Anticancer Res 2: 245–250
Kiang DT, Dennedy BJ (1977) Estrogen receptor assay in the differential diagnosis of adenocarcinomas. JAMA 238: 32–34
McClendon JE, Appleby D, Clandon DB, Donegan WL, De Cosse JJ (1977) Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen. Arch Surg 112: 240–241
Alford TC, Do H-M, Geelhoed GW, Tsangaris NT, Lippman ME (1979) Steroid hormone receptors in human colon cancers. Cancer 43:980–984
Carson E, Antuoro L, Brockmeyer D, Critselis AN (1980) Estrogen and progesterone receptors in colon carcinoma (preliminary report). Clin Res 28: 682A
Leake RE, Laing L, Calman KC, Macbeth FR (1980) Estrogen receptors and antiestrogen therapy in selected human solid tumors. Cancer Treat Rep 64:797–799
Maillot KV, Hermanek P, Gentsch HH, Ober KG (1980) Steroid receptors in malignant tumors of male patients. In: Wittlift JL, Dapunt O (eds) Steroid receptors and hormone-dependent neoplasia. Masson Publ., New York, pp 215–218
Sica V, Contièri E, Nola E, Bova R, Papaleo G, Puca GA (1981) Estrogen and progesterone binding proteines in human colorectal cancer. A preliminary characterization of estradiol receptor. Tumori 67:307–314
Panettiere FJ, Timothy T, Rogers C (1982) SWOG trial of tamoxifen in patients with advanced colorectal adenocarcinoma. Proc Am Soc Clin Oncol 23 : C-364
Literatur
Asseo PP, Tracopoulos GD (1982) Simultaneous enzyme immunoassay of CEA in pleural effusion and serum. Am Soc Clin Pathol 77: 66–71
Blair OM, Goldenberg DM (1974) A correlative study of bronchial cytology, bronchial washing CEA, and plasma CEA in the diagnosis of bronchogenic cancer. Acta Cytol (Baltimore) 18: 510–514
Gold P, Freedman SO (1965) Demonstration of tumor specific antigens in human colonic carcinomata by immunologic tolerance an absorption techniques. J Exp Med 121: 439–462
Literatur
Hansen M, Hummer M (1979) Ectopic hormone production in small cell carcinoma. In: Muggia F, Rosenzweig M (eds) Lung cancer progress in therapeutic research. Raven Press, New York, pp 199–207
Luster W, Gropp C, Sostmann H, Kalbfleisch H, Havemann K (1982) Demonstration of immunoreactive calcitonin in sera and tissues of lung cancer patients. Eur J Cancer Clin Oncol 18:1275–1283
Gropp C, Havemann K, Kalbfleisch H, Luster W, Sostmann H (1982) Antidiuretisches Hormon bei Patienten mit Bronchialkarzinom. Dtsch Med Wochenschr 107: 974–977
Gropp C, Havemann K, Scheuer A (1980) Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer 46: 347–354
Havemann K, Gropp C, Scheuer A, Scherfe T, Gramse M (1979) ACTH-like activity in immune complexes of patients with oatcell carcinoma of the lung. Br J Cancer 39:43–50
Goldstein IJ, Hollermann CE, Smith EE (1965) Proteincarbohydrate interaction. II. Inhibition studies on the interaction of concavalin A with polysaccharides. Biochemistry 4: 876–883
Gazdar AF, Carney DN, Guccion IG, Baylin SB (1981) Small cell carcinoma of the lung: cellular origin and relationship to other pulmonary tumors. In: Greco FA, Oldham RK, Bunn PA (eds) Small cell lung cancer. Grune and Stratton, New York, pp 145–176
Nakanishi S, Inoue A, Kita T, Nakamura M, Chany ACY, Cohen SN, Numa S (1979) Nucleotide sequence of cloned cDNA for bovine corticitropin-β-lipotropin precursor. Nature 278: 423–427
Mains RE, Eipper BA, Ling N (1977) Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 74:3014–3018
Literatur
Hehlmann R, Baumgarten A, Schreiber MA, Schetters H, Luz A, Mesa-Tejada R, Lohe KJ, Prechtel K (1981) Kreuzreaktion menschlicher Mammakarzinome mit dem Hüllglykoprotein gp52 des Mausmam-matumorvirus (MMTV). Verh Dtsch Ges Pathol 65:275–279
Hehlmann R, Baumgarten A, Schreiber MA, Schetters H, Luz A, Mesa-Tejada R, Lohe KJ, Prechtel K (1982) Crossreaction of antigens in sections of human breast cancers with the envelope glycoprotein gp52 of the mouse mammary tumor virus: a marker for human mammary carcinoma— Eur J Cancer Clin Oncol 18:1399
Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659–670
Mesa-Tejada R, Keydar I, Ramanarayanan M, OhnoT, Fenoglio C, Spiegelman S (1978) The detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of the mouse mammary tumor virus. Proc Natl Acad Sci USA 75:1529–1533
Mesa-Tejada R, Oster MW, Fenoglio CM, Magidson J, Spiegelman S (1982) Diagnosis of primary breast carcinoma through immunohistochemical detection of mouse mammary tumor virus-related antigen in metastatic lesions. A report of two cases. Cancer 49:261–268
Ohno T, Mesa-Tejada R, Keydar I, Ramanarayanan M, Bausch J, Spiegelman S (1979) The human breast carcinoma antigen is immunologically related to the polypeptide of the group-specific glyoprotein of the mouse mammary tumor virus. Proc Nat Acad Sci USA 76:2460–2464
Prechtel K, Schmidt H, Gehm O (1982) Langzeitbeobachtung von Frauen mit bioptisch gesicherten Mastopathien unterschiedlicher Schwe-regrade. In: Bohmert H (Hrsg) Brustkrebs und Brustrekonstruktion. Thieme, Stuttgart: 58–61
Spiegelman S, Keydar I, Mesa-Tejada, R, Ohno T, Ramanarayanan M, Nayak R, Bausch J, Fenoglio C (1980) Possible diagnostic implications of a mammary tumor virus related protein in human breast cancer. Cancer 46:879–892
Literatur
Bleyer WA (1978) The clinical pharmacology of methotrexate. Cancer 41: 36–51
Djerassi I et al. (1972) Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer 30: 22–30
Jaffe N et al. (1974) Adjuvant methotrexate and citrovorum factor treatment of osteogenic sarcoma. N Engl J Med 291:994–997
Methotrexate (125J) radioimmunoassay kit instruction manual. Diagnostic Biochemistry Inc., San Diego, California, 1978
Rosen G et al. (1980) Response of primary osteogenic sarcoma to single agent therapy with high-dose methotrexate with citrovorum factor rescue. Proc. 11th ICC and 19th ICAAC
Sauer H, Schalhorn A (1980) Rationale Grundlagen und Praxis des Citrovorumfaktor(Leucovorin)-Schutzes nach hochdosierter Methotrexat-Therapie. Onkologie 3: 64–71
Schalhorn A et al. (1980) Methotrexat-Nachweis im menschlichen Serum — Vergleich zwischen einer enzymatischen und einer enzymimmunologischen Methode. Onkologie 4:193–196
Schalhorn A et al. (1982) Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate. Cancer Chemother Pharmacol 9: 65–69
Schalhorn A et al. (1983) Methotrexate and methotrexate polyglutamate in human sarcoma metastases after high-dose methotrexate therapy, (eingereicht zur Publikation)
Wilmanns W, Martin H (1968) Wirkung und Verteilung von Methotrexat im menschlichen Organismus bei der Leukämiebehandlung. Klin Wochenschr 46: 281–296
Literatur
Fiebig HH, Henß H, Schuchhardt C, Löhr GW (1982) Xenotransplantation und Chemotherapie menschlicher Tumoren, Vergleich des Ansprechens der Malignome beim Patienten und in der Nacktmaus. Verh Dtsch Ges Inn Med 88: 966–969
Fiebig HH, von Kleist S (1982) Carcinoembryonic antigen (CEA) in human colorectal cancers growing subcutaneously in nude mice. J Cancer Res Clin Oncol (in press)
Pantelouris EM (1968) Absence of the thymus in a mouse mutant. Nature 217:370
Literatur
Hamburger A, Salmon SE (1977) Primary bioassay on human tumor stem cells. Science 197: 461–463
von Hoff DD, Caspar J, Bradley E, Sandbach J, Jones D, Makuch R (1981) Association between human tumor colony-forming assay results and response of an individual patient’s tumor to chemotherapy. Am J Med 70:1027–1032
Nelson RL, Dyke RW, Root MA (1980) Comparative pharmacokinetics of Vindesine, Vincristine and Vinblastine in patients with cancer. Cancer Treat Rev 7: 17–24
Salmon SE, Hamburger AW, Soehnlen B, Durie BGM, Alberts DS, Moon TE (1978) Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321–1327
Stephenson JR, Axelrad AA, McLeod DL, Shreeve MM (1971) Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci USA 68:1542;1546
Literatur
Kennedy PS, Luedke DW (1979) Adenocarcinoma of unknown origin. A rational approach to a diagnostic puzzle. Postgrad Med 65:151
Nissenblatt MG (1981) The CUP syndrome (carcinoma unknown primary). Cancer Treat Rev 8:211
Literatur
Hegemann G, Mühe E (1976) Exstirpation von Metastasen. Langenbecks Arch Chir 342:261
Fischer J, Weigand H, Preiß J (1983) Regionale Chemotherapie von Lebermetastasen. In: Fischer J (Hrsg) Taschenbuch der Onkologie. Urban u. Schwarzenberg, S 118 ff
Chen H-SG, Gross JF Intra arterial infusion of anticancer drugs: Theoretic aspects of drug delivery and review of responses
Jaffe BM, Donegan WL, Watson F (1968) An investigation of the factors which influence the survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127:1
Literatur
Bruntsch U, Gallmeier WM (1980) Schmerztherapie im fortgeschrittenen Krebsstadium. Münch Med Wochenschr 122: 7–9
Catalano RB (1975) The medical approach to management of pain caused by cancer. Semin Oncol 2: 379–392
Melzack R, Mount BM, Gordon JM (1979) The Brompton mixture versus morphine solention given orally: effects on pain. Can Med Assoc J 120: 435–438
Moertel CG, Ahmann DL, Taylor WF, Schwartau N (1972) A comparative evaluation of marketed analgesic drugs. N Engl J Med 286: 813–815
Moertel CG, Ahmann DL, Taylor WF, Schwartau N (1974) A controlled evaluation of analgesic combinations. JAMA 229: 55–59
Schlegel G (1982) Die Therapie des Tumorschmerzes. Tumor Diagnostik 3:10–16
Schreml W, Merkle W, Heimpel H (1981) Medikamentöse Schmerztherapie bei Krebspatienten. Med Klin 76:43–47
Senn HJ, Glaus A (1982) Schmerz und Schmerzbekämpfung bei Tumorleiden. Schweiz Med Wochenschr 112:1158–1164
Twycross RG (1974) Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol Biopharm 9:184–198
Twycross RG (1977) Choice of analgesics in terminal cancer. Practitioner 219:475–478
Literatur
Carcassone M (1982) Les.effets de l’alizapride dans les vomissements chez le nourrisson et l’enfant. Sem Hop Paris 58: 357–361
Casanova P, Girard D (1982) Etude comparative alizapride-metopimazine. Sem Hop Paris 58:345–348
Girard D, Salles E, Bel A (1982) Etude des effets d’un nouneau benzamide, l’alizapride, dans les nausees et les vomissements en medicine interne. Sem Hop Paris 58: 353–358
Gralla JG, Loretta MI, Pisco SE, Squillante AE, Kelsen DP, Braun DW, Bordin LA, Braun TJ, Young CW (1981) Antimetic effica-cy of high dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vometing. N Engl J Med 305: 905–909
Houin G, Bree F, Tillement JP (1982) Pharmacocinetique et biodisponibilite de l’alizapride chez l’homme. Sem Hop Paris 58:339–344
Literatur
Balkwill FR (1979) Interferons as cell-regulatory molecules. Cancer Immunol Immunother 7: 7–14
Evinger M, Maeda S, Pestka S (1981) Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity. J Biol Chem 256:2113–2114
Gutterman JU, Blumenschein GR, Alexanian R, Yap H-Y, Buzdar AU, Cabanillas F, Hortobagyi GN, Hersh EM, Rasmussen SL, Harmon M, Kramer M, Pestka S (1980) Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 93: 399–406
Herberman RB, Djeu JY, Ortaldo JR, Holden HT, West WH, Bonnard GD (1978) Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. Cancer Treat Rep 62: 1893–1896
Maeda S, McCandliss R, Gross M, Sloma A, Familletti PC, Tabor JM, Evinger M, Levy WP, Pestka S (1980) Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Proc Natl Acad Sci USA 77: 7010–7013
Mellstedt H, Björkhom M, Johansson B, Ahre A, Holm G, Strander H (1979) Interferon therapy in myelomatosis. Lancet 1: 245–247
Merigan TC, Sikora K, Breeden JH, Levy R, Rosenberg SA (1978) Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin’s lymphoma. N Engl J Med 299:1449–1453
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214
Priestman TJ (1979) Interferon: an anti-cancer agent? Cancer Treat Rev 6: 223–237
Sherwin SA, Knost JA, Fein S, Abrams PG, Foon KA, Ochs JJ, Schoenberger C, Maluish AE, Oldham RK (1982) A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. JAMA 248:2461–2466
Literatur
MacDonald JS, Boiron M, Brunet R, Gisselbrecht C, Lagarde C, Schein PS, Woolley PV (1979) FAM combination chemotherapy results in 61 patients with advanced gastric cancer. Proc Am Assoc Cancer Res/ASCO 20:C-434
Queißer W, Schnitzler G, Schäfer J, Arnold H, Drings P, Fritze D, Geldmacher J, Hartwich G, Herrmann R, Kempf P, König H, Meiser RJ, Nedden R, von Oldershausen H-F, Pappas A, Sievers H, Wahrendorf J, Westerhausen M, Witte S (1981) Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma. Recent Results Cancer Res 79:82
Literatur
Dekker AW, Rozenberg-Arska M, Sixma JJ, Verhoef J (1981) Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med 95: 555–559
Gurwith MJ, Brunton JL, Lank BA, Harding GKM, Ronald AR (1979) A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66: 248–256
Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Succesful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297:1419–1426
Krieger D, Vanek E, Strehle R (1981) Influence of total and selective decontamination on the aerobic and anaerobic gastrointestinal flora in patients with acute leukaemia. In: Sasaki S, Ozawa A, Hashimoto K (eds) Recent advances in germfree research. Tokai University Press, Tokyo, pp 715–718
Kurrle E (1981) Infektprophylaxe bei der Induktionstherapie akuter Leukämien. Klin Wochenschr 59:1075–1079
Sleijfer DT, Mulder NH, de Vries-Hospers HG, Fidler V, Nieweg HO, van der Waaij D, van Saene HKF (1980) Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16: 859–869
Van der Waaij D (1979) The colonization resistance of the digestive tract in man and animals. Zentralbl Bakteriol (Suppl) 7: 155–161
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 J. F. Bergmann Verlag, München
About this paper
Cite this paper
Bodemann, H.H. et al. (1983). Hämatologie/Onkologie. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 89. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85456-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-85456-9_19
Publisher Name: J.F. Bergmann-Verlag
Print ISBN: 978-3-8070-0335-1
Online ISBN: 978-3-642-85456-9
eBook Packages: Springer Book Archive